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Abstract Carbon-ion radiotherapy (CIRT) is gener-
ally evaluated with the dose weighted by relative bi-
ological effectiveness (RBE), while the radiation qual-
ity varying in the body of each patient is ignored for
lack of such distribution. In this study, we attempted
to develop a method to estimate linear energy transfer
(LET) for a treatment planning system that only han-
dled physical and RBE-weighted doses. The LET taken
from a database of clinical broad beams was related to
the RBE per energy with two polyline fitting functions
for spread-out Bragg peak (SOBP) and for entrance
depths, which would be selected by RBE threshold per
energy per modulation. The LET estimation was con-
sistent with the original calculation typically within a
few keV/µm except for the overkill at the distal end
of SOBP. The CIRT treatments can thus be related
to the knowledge obtained in radiobiology experiments
that used LET to represent radiation quality.
Keywords relative biological effectiveness · linear
energy transfer · carbon-ion radiotherapy · treatment
planning · retrospective analysis
1 Introduction
Use of heavy charged particles for cancer treatment was
initiated by historical pioneers [1], and is rapidly ex-
panding worldwide [2]. In particular, carbon-ion radio-
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therapy (CIRT) features finely customizable dose dis-
tribution with concurrent enhancement of relative bio-
logical effectiveness (RBE), and has been practiced for
over 20 years with technological innovations and clinical
outcomes [3]. However, despite continuous efforts in ex-
perimental radiobiology [4], the radiobiological knowl-
edge has been applied to CIRT only conceptually per
disease [5]. The application to individual treatments has
been limited for the difficulty in quantifying the radia-
tion quality, or spectrum of ionizing particles, varying
in the body of each patient.
In CIRT, dose D weighted by RBE rBE, or RBE-
weighted dose rBED, is commonly used for treatment
planning. The RBE is generally defined as
rBE =
Dref
D
∣
∣
∣
∣
endpoint
, (1)
where Dref is the dose of a reference radiation for the
same biological endpoint of a reference cell line as with
the current dose. Among other influential factors for
RBE, the radiation quality is generally most focused
and is typically represented by linear energy transfer
(LET) to tissue per ion track averaged with dose weight-
ing (dose-averaged) [6,7], or
LD =
∑
i
LiDi∑
i
Di
≈
∑
i
S2
i∑
i
Si
, (2)
where Li is the LET from ion track i, Di is its dose
contribution (∝ Li), and Si is the stopping power of
water for the ion [8], or the expectation value of the
LET. While the RBE is the effectiveness of the current
dose for reference cells in a reference condition, the LET
(dose-averaged, unless otherwise noted hereafter) may
potentially give a clue to the sensitivity of various cells
in various conditions based on the collection of radio-
biology experiments with ion beams [9,4]. The spatial
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distribution of LET for each CIRT plan, if available,
will thus allow radiation oncologists to further consider
the radiosensitivity of relevant tissue cells [10].
Clinical studies on CIRT have been conducted with
a broad-beam facility at the National Institute of Ra-
diological Sciences (NIRS) in Japan since 1994 [11,12],
where two systems were mainly used for treatment plan-
ning. The first system HIPLAN (in-house development)
employed the broad-beam algorithm ignoring beam blur-
ring except around field edges [13]. The second sys-
tem XiO-N (Mitsubishi Electric, Tokyo) employed the
pencil-beam algorithm for more accurate heterogene-
ity correction [14]. These systems were intrinsically de-
signed to be used with the clinical RBE of original NIRS
definition: The particle spectrum including projectile
fragments was semi-analytically simulated in water [15].
In the linear quadratic (LQ) modeling of the carbon-
ion beams [11], the dose-averaged LET was used as a
parameter to relate the dose to the survival of human
salivary gland tumor (HSG) cells in radiobiology ex-
periments [6]. The RBE varying with depth (in water,
unless otherwise noted) was calculated for the endpoint
of 10% survival fraction (SF) with rescaling to 3.0 at
80 keV/µm for the compatibility with historical fast-
neutron therapy in dose prescription [16].
With the launch of a scanning-beam facility at NIRS
in 2011, the clinical RBE was reformulated using the
microdosimetric kinetic model with Monte Carlo simu-
lation for accurate handling of secondary particles, for a
plan-specific endpoint of variable SF, and against a ref-
erence carbon-ion radiation with rescaling for the com-
patibility of dose prescription [17]. Around the same
time, an extra energy of E/A = 430 MeV was intro-
duced and all the ridge filters were remanufactured for
the broad-beam system to follow the new RBE defini-
tion for a slightly modified endpoint of 30% in HSG-cell
SF, or the most common prescription of 3.6 Gy in RBE-
weighted dose [18]. The XiO-N system was set up for
the clinical use with the reconfigured beams despite un-
der its intrinsic limitation of the fixed SF regardless of
actual dose prescription.
The HIPLAN system could optionally calculate the
distributions of physical dose and LET as well as RBE-
weighted dose, though the functionality was opted out
for more than 7000 patients in the past. The XiO-N
system has automatically stored the physical and RBE-
weighted dose distributions for more than 2000 patients
so far in preparation for possible verification dosimetry.
To provide LET distributions for retrospective analy-
sis of the archived XiO-N plans and for ongoing treat-
ments, the obsolete HIPLAN system must be reused
for less accurate and troublesome plan reproduction. In
this study, we have attempted to develop an alternative
and potentially semiautomatic method to derive LET
distributions for the XiO-N plans.
2 Materials and methods
2.1 Clinical carbon-ion beams
For broad-beam CIRT at NIRS, carbon ions of kinetic
energy per nucleon E/A = 290, 350, or 400 MeV have
been mainly used with a wobbler-scatterer system for
field formation, a selectable ridge filter for range mod-
ulation between M = 2 cm and 15 cm, and a variable
range shifter so that any tumor can be optimally cov-
ered with a spread-out Bragg peak (SOBP) [19]. The
HIPLAN system was set up with the beam data includ-
ing physical dose, RBE-weighted dose, and LET, which
all are of theoretical calculation as functions of depth.
The XiO-N system was set up with measured physical
dose and redefined RBE.
Figure 1 shows a typical clinical beam registered in
the HIPLAN and XiO-N systems. The high similarity
between the two systems suggests that the differences
in physical modeling and in biological endpoint were
mostly minor or canceling. To deal with such modulated
beams, we defined three depth regions: d < R − M
(Entrance),R−M ≤ d ≤ R (SOBP), and R < d ≤ R+5
cm (Tail), where d is the depth in water and R is the
beam range of continuous slowing-down approximation
[8] and the depths of d > R+5 cm were excluded for the
insufficient number of significant digits for the HIPLAN
doses. The RBE of XiO-N was thus related to the LET
of HIPLAN at 1-mm depth intervals for each beam.
A portion of primary carbon ions break up into sec-
ondary fragments by the nuclear interactions with mat-
ter, whose yield may vary with range or initial beam
energy. In the Entrance region, the carbon ions have
relatively low LET, and strong positive correlation is
theoretically expected between LET and RBE [20]. In
the SOBP region, the locally stopping high-LET carbon
ions cause the saturated biological effect, or overkill,
and spoil the correlation especially when mixed with
low-LET fragments. In the Tail region, the fragments
of wide variety in LET dominate, though with low dose.
2.2 Formulation of RBE–LET relations
We formulated LET estimation LˆD covering all the clin-
ical beams per energy with manually fitted polyline
functions of RBE, where the Entrance and SOBP re-
gions were handled separately to deal with discontinu-
ity at their boundary as implied by Fig. 1. The Tail
Estimation of LET for carbon-ion radiotherapy 3
0
0.5
1 (a)
D
 / 
D m
id
0
1
2
(b)
r B
E 
D
 / 
D m
id
0
50
100
150
-20 -15 -10 -5 0 5
(c)
(d - R) / cm
L D
 
/ (k
eV
/mm
)
Fig. 1 (a) Physical dose D and (b) RBE-weighted dose
rBED relative to mid-SOBP dose Dmid, and (c) LET LD
as functions of range-subtracted depth (d−R) in water regis-
tered in HIPLAN (solid lines) and in XiO-N (dashed lines) for
the beam of E/A = 350 MeV andM = 6 cm, and boundaries
between the Entrance, SOBP, and Tail depth regions (dotted
lines).
region was ignored for its similarity to the Entrance re-
gion in RBE as well as for its low dose contribution.
The indifference to the fragments may also be justified
by their theoretical difficulty such that even advanced
Monte Carlo simulation required empirical correction
for them [21].
To select either polyline to apply for a single LˆD
value, we took the RBE at the proximal end of SOBP,
or at d = R − M , as the RBE threshold rBEth per
energy per modulation. For a RBE above the threshold,
the function for SOBP will be applied, or otherwise the
function for Entrance will be applied, to estimate the
LET.
2.3 Application of LET estimation
LET reproducibility We estimated LET from RBE of
XiO-N and compared with the LET of HIPLAN for
the beam of E/A = 350 MeV and M = 6 cm, where
the beam range was virtually adjusted to set the SOBP
center position at the isocenter in water.
Radiation mixing Similarly, we simulated an opposing
arrangement of the same beams to examine the radiation-
mixing effect. We first estimated LET from RBE of
Table 1 RBE–LET relations (rBE, Lˆ/u) with u = 1 keV/µm
for XiO-N, to constitute the polyline fitting functions for En-
trance and for SOBP of E/A = 290, 350, and 430 MeV.
(rBE, Lˆ/u)
SOBP
№ Entrance 290 MeV 350 MeV 400 MeV
1 (1.0, 0) (1.0, 0) (1.0, 0) (1.0, 0)
2 (4.0, 84) (2.0, 31) (2.0, 33) (2.0, 33)
3 (2.6, 55) (2.6, 56) (2.6, 56)
4 (3.0, 72) (3.0, 79) (3.0, 85)
5 (4.0, 140) (4.0, 170) (4.0, 180)
XiO-N for the individual beams, then applied dose-
averaging over the beams, and compared the resultant
LET estimation with the dose-averaged LET of HIPLAN.
3 Results
3.1 Formulation of RBE–LET relations
Figure 2 shows the correlation between LET and RBE
for E/A = 350 MeV with the polyline fitting functions,
where we ignored the entries around rBE & 3.0 and
LD & 100 keV/µm at the distal end of SOBP, where
severe overkill should occur, to make the function as
single-valued. Table 1 enumerates the polyline fitting
results for all the HIPLAN energies, where a single lin-
ear relation was commonly applicable to Entrance as
expected while the overkill effect slightly increased with
energy for SOBP.
Table 2 shows the RBE at the proximal end of SOBP,
or RBE threshold rBEth, per energy per modulation.
For E/A = 430 MeV, which was not supported by
HIPLAN, the fitting functions for 400 MeV should be
applied as the best alternative. Figure 3 shows the dis-
tributions of residual deviation between the LET esti-
mated from RBE of XiO-N and the LET of HIPLAN for
E/A = 350 MeV, where the RBE threshold separated
the SOBP from the other regions effectively and the
(mean ± standard deviation) amounted to (−0.01 ±
1.30) keV/µm for rBE < rBEth and (−0.60 ± 5.98)
keV/µm for rBE ≥ rBEth.
3.2 Application of LET estimation
LET reproducibility Figure 4 shows the RBE and LET
distributions in the single-beam case. The LET estima-
tion generally agreed well with the LET of HIPLAN
except for the peak at the distal end of SOBP and for
Tail, as it was designed as such. The peak LET of 157
keV/µm was underestimated by 26%.
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Fig. 2 Dose-weighted frequency distributions of LET and
RBE of XiO-N, accumulated over all modulated beams of
E/A = 350 MeV for 1-mm-interval depths of (a) Entrance
and (b) SOBP with polyline fitting functions (dashed lines),
and of (c) Tail.
Table 2 RBE thresholds rBEth for E/A = 290, 350, 400, and
430 MeV per range modulation M , to select the function ei-
ther for Entrance (rBE < rBEth) or for SOBP (rBE ≥ rBEth)
to estimate LET for XiO-N.
rBEth
M/cm 290 MeV 350 MeV 400 MeV 430 MeV
2.0 2.769 2.690 2.619 2.563
2.5 2.632 2.565 2.498 2.447
3.0 2.525 2.466 2.404 2.358
4.0 2.378 2.314 2.254 2.213
5.0 2.263 2.203 2.147 2.117
6.0 2.176 2.116 2.060 2.021
7.0 2.094 2.045 1.989 1.957
8.0 2.040 1.982 1.935 1.903
9.0 1.984 1.932 1.882 1.853
10.0 1.941 1.888 1.842 1.812
11.0 1.900 1.848 1.805 1.775
12.0 1.860 1.814 1.771 1.742
15.0 — 1.726 1.686 1.660
Radiation mixing Figure 5 shows the dose-averagedRBE
and LET distributions in the opposing-beam case. Even
with radiation mixing, the LET estimation generally
agreed well with the LET of HIPLAN. The disagree-
ment observed for Tail of the single beam was mitigated
by dose averaging with Entrance of another beam, while
the peak LET of 84 keV/µm was still underestimated
by 20%.
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Fig. 3 Dose-weighted frequency distributions of residual de-
viation between the LET LˆD estimated from RBE of XiO-N
and the LET LD of HIPLAN: (a) for rBE < rBEth and (b)
for rBE ≥ rBEth, at 1-mm-interval depths of all modulated
beams of E/A = 350 MeV. The histogram entries were con-
stituted by Entrance (dark gray), SOBP (medium gray), and
Tail (light gray).
1
1.5
2
2.5
3
3.5
4
(a)
r B
E
0
50
100
150
-5 0 5
(b)
Position in water, z/cm
L D
 
/ (k
eV
/mm
)
Fig. 4 Distributions of (a) RBE of XiO-N and (b) LETs of
XiO-N estimation LˆD (solid) and of HIPLAN LD (dashed)
along the beam central axis in water for a single beam of
E/A = 350 MeV and M = 6 cm.
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Fig. 5 Distributions of (a) RBE of XiO-N and (b) LETs of
XiO-N estimation LˆD (solid) and of HIPLAN LD (dashed)
along the beam central axis in water for opposing beams of
E/A = 350 MeV and M = 6 cm.
4 Discussion
The present LET estimation was formulated for the
RBE that was defined for a fixed SF, or independently
of dose, though conceptually against the LQ model.
With dose-dependent RBE, the dose must also be con-
sidered for the LET estimation. The LET data excerpted
from HIPLAN only covered primary carbon ions and
projectile fragments, which may be acceptable for the
following reasons. The target nuclear fragments and re-
coils are highly ionizing and short ranged, and thus dif-
ficult to calculate theoretically or to measure experi-
mentally. In addition, the LET of the same definition
has been commonly used to represent radiation quality
in radiobiology experiments as well.
For a LET as high as to cause overkill, single-valued
LET estimation from RBE is intrinsically limited. Hope-
fully, that will not be clinically critical because such a
overkill region is likely in the margin against the poten-
tial spread of cancer cells around a tumor. Conversely,
the insensitivity to overkill may be an intrinsic defi-
ciency of LET for a clinical index of radiation quality,
and could confuse treatment analysis, especially with
dose averaging over multiple beams. In this regard, the
direct use of RBE distributions may offer better cor-
relation with the clinical results because the overkill
effect has been corrected for the HSG cells which were
assumed to represent all cells.
The estimation of LET from RBE was demonstrated
to work for the sample beam, and should naturally work
for the other clinical broad beams of NIRS as well. The
correlation between RBE and LET was high as illus-
trated in Fig. 2, which was also true for the other en-
ergies, and the variation of LET–RBE relation among
energies was rather marginal as shown in Table 1. This
fact may also justify the application of the fitting func-
tion for 400 MeV to 430 MeV. Because the RBE in En-
trance and Tail should always be lower than the RBE
threshold, or the minimum RBE in SOBP, the appro-
priate function can be selected reliably by the RBE
comparison according to Table 2. The present LET es-
timation was intended for the broad beams of CIRT at
NIRS, and may approximately apply to similar beams
at other CIRT facilities.
5 Conclusions
For the CIRT treatments of over 2000 patients planned
with the XiO-N system, we have developed a method to
estimate their LET distributions from the RBE distri-
butions available from the plans. The estimated LET
was consistent with the original calculation typically
within a few keV/µm in deviation except for the overkill
at the distal end of SOBP. The LET estimation to re-
late radiation quality of CIRT to that of radiobiology
experiments will facilitate the radiobiological interpre-
tation of the treatments retrospectively or prospectively
in treatment planning.
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